Pulmonary Function Testing Devices Market By Product (Portable PFT Devices, Complete PFT Devices), By Test Type (Spirometry, Peak flow meter, Lung Volume Test, Gas Exchange Testing, Maximal Voluntary Ventilation, Others), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, Others), By End user (Hospital, Clinical laboratories, Diagnostic Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Pulmonary Function Testing Devices Market

Pulmonary function testing refers to devices that are utilized to identify pulmonary impairment and respiratory issues. The issues related to respiration have accelerated because of the increasing consumption of cigarettes, climate change, and increasing air pollution. These systems are used to measure the rate of flow, lung volume capacity, and gas exchange. The systems assist in diagnosing lung disorders and selecting treatments or therapeutics for lung disorders.

The key factors that drive the Pulmonary Function Testing Devices Market growth are the rise in the prevalence of lung cancer, COPD, asthma, emphysema, and others across the world. Moreover, the increase in the geriatric population is the major factor contributing to the growth of the market. For instance, elderly people are more susceptible to lung disease. According to a report published by the American Cancer Society, it was estimated that about 236,740 new cases of lung cancer was diagnosed in the U.S. in 2022. Furthermore, it was estimated that most of people diagnosed with lung cancer in the U.S. are 65 or older.

However, high cost of the pulmonary test and lack of awareness about the latest diagnosis test hinder the growth of the market. Furthermore, rapid increase in the prevalence of lung disease and rise in healthcare facilities along with surge in health expenditure among developing countries provide lucrative opportunities for the growth of the market.

The Pulmonary Function Testing Industry is segmented on the basis of test type, application, product, end user, and region. By test type, the market is segmented into spirometry, peak flow meter, lung volume, gas exchange testing, maximal voluntary ventilation, and others. By application, it is segmented into chronic obstructive pulmonary disorders, asthma, chronic shortness of breath, restrictive lung disease and others. By product, it is segmented into portable PFT devices and complete PFT systems. By end user, the market is segmented into hospitals, diagnostic centers, clinical laboratories, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

On the basis of product, the market is segmented into portable PFT devices and complete PFT systems. The portable PFT device segment exhibited the highest growth in 2021 and is anticipated to lead during the forecast period, owing to the rise in the prevalence of lung cancer and other lung-related disorder which increases the demand for non-invasive tests that measure the capacity of lung.

On the basis of test type, the pulmonary function testing devices market is segmented into spirometry, lung volume, gas exchange testing, maximal voluntary ventilation, and others. In 2021, the spirometry segment accounted for the largest share of the market. The dominance of this segment is attributed to an increase in the prevalence of asthma and other lung-related disorders across the world.

On the basis of application, the market is segmented into chronic obstructive pulmonary disorders, asthma, chronic shortness of breath, restrictive lung disease, and others. The chronic obstructive pulmonary disorders segment exhibited the highest growth in 2021 and is anticipated to lead during the forecast period, owing to a rise in the geriatric population and an increase in the prevalence of COPD among adults.

By end user, the market is segmented into hospitals, clinical laboratories, diagnostic centers, and others. The hospital's segment exhibited the highest growth in 2021 and is anticipated to lead during the forecast period, owing to the increase in the number of patients visit to hospitals for the diagnosis of lung-related disorders across the world.

North America accounted for a majority of the pulmonary function testing devices market share in 2021 and is anticipated to remain dominant during the forecast period owing to the increase in healthcare expenditure and the presence of major players in the region.

Asia-Pacific was the second largest contributor to the market in 2021 and is expected to register the fastest CAGR during the forecast period, owing to a rise in the prevalence of chronic diseases and an increase in the geriatric population in developing countries like India and China.

The key players that operate in the pulmonary function testing devices market are Chest M.I Inc, Clarity Medical Pvt. Ltd., Cosmed srl, Data Sciences International Inc, Eco Medics AG, Geratherm Medical AG, JK Medical System Pvt. Ltd., Medical Electronic Construction, Medical Equipment Europe GmbH, MGC Diagnostics Corporation, Morgan Scientific Inc, NDD Medical Technologies Inc, Omron Corporation, Pulm One Advanced Medical Devices Ltd., Schiller AG, Koko LLC, and Vyaire Medical Inc.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the pulmonary function testing systems market, and the current trends and future estimations to elucidate imminent investment pockets.

It presents a quantitative analysis of the market from 2022 to 2031 to enable stakeholders to capitalize on the prevailing market opportunities.

Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.

Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Overview

Pulmonary function testing is a series of tests that can determine as well as measure the efficacy of inhaling and exhaling functions performed by the lungs. It plays a pivotal role in determining the efficient transfer of oxygen into the blood and helps in diagnosing certain types of lung diseases such as asthma, bronchitis, and emphysema, along with determining the cause of shortness of breath.

Some of the common types of pulmonary function tests are spirometry. Spirometry measures how much air a person can breathe in and out. It also measures how fast a person can empty the air out of the lungs. This test is done to check how well the oxygen moves from the lungs into the bloodstream.

The key factors that drive the growth of the market are the rise in the prevalence of lung cancer and lung-related disorders; rise in the geriatric population; and the increase in adoption of technologically advanced medical devices across the world. In addition, rise in the demand for minimally invasive tests for lung diseases across the key is the key factor which further boosts the market growth. For instance, according to the World Health Organization, in 2020, chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide. It was estimated that around 3.9 million people died due to COPD. Furthermore, increase in the geriatric population and the rise in the prevalence of chronic lung diseases has increased the demand pulmonary function testing devices for disease diagnosis across the world which further boost the market growth.

Moreover, increase in R&D activity for pulmonary function testing devices, and a rise in healthcare expenditures further boost the growth of market. However, the high cost of medical devices and a lack of awareness of pulmonary tests hamper the market growth. Conversely, the emerging healthcare market in developing countries is expected to provide a lucrative opportunity for the key players operating in the market during the forecast period.

The pulmonary function testing devices market is segmented on the basis of product, test type, application, end user, and region. On the basis of product, it is segmented into portable PFT devices and complete PFT systems. On the basis of test type, the market is segmented into spirometry, peak flow meter, lung volume test, gas exchange testing, maximal voluntary ventilation, and others. On the basis of application, it is segmented into chronic obstructive pulmonary disorders, asthma, chronic shortness of breath, restrictive lung disease and others. On the basis of end user, the market is segmented into hospitals, diagnostic centers, clinical laboratories and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America dominated pulmonary function testing devices in 2021 and is anticipated to remain dominant during the forecast period due to rise in healthcare expenditure and the presence of major players in the in this region.

Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rise in prevalence of chronic diseases and increase in geriatric population.

The key players that operate in the pulmonary function testing devices market are Chest M.I Inc, Clarity Medical Pvt. Ltd., Cosmed srl, Data Sciences International Inc, Eco Medics AG, Geratherm Medical AG, JK Medical System Pvt. Ltd., Medical Electronic Construction, Medical Equipment Europe GmbH, MGC Diagnostics Corporation, Morgan Scientific Inc, NDD Medical Technologies Inc, Omron Corporation, Pulm One Advanced Medical Devices Ltd., Schiller AG, Koko LLC, and Vyaire Medical Inc

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pulmonary function testing devices market analysis from 2021 to 2031 to identify the prevailing pulmonary function testing devices market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the pulmonary function testing devices market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global pulmonary function testing devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Medical Equipment Europ

Scope of Pulmonary Function Testing Devices Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Portable PFT Devices

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.2.4 Portable PFT Devices Pulmonary Function Testing Devices Market by Type

4.2.4.1 Hardware Market size and forecast, by region

4.2.4.2 Software Market size and forecast, by region

4.3 Complete PFT Devices

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.3.4 Complete PFT Devices Pulmonary Function Testing Devices Market by Type

4.3.4.1 Hardware Market size and forecast, by region

4.3.4.2 Software Market size and forecast, by region

5.1 Overview

5.1.1 Market size and forecast

5.2 Spirometry

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Peak flow meter

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Lung Volume Test

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

5.5 Gas Exchange Testing

5.5.1 Key market trends, growth factors and opportunities

5.5.2 Market size and forecast, by region

5.5.3 Market analysis by country

5.6 Maximal Voluntary Ventilation

5.6.1 Key market trends, growth factors and opportunities

5.6.2 Market size and forecast, by region

5.6.3 Market analysis by country

5.7 Others

5.7.1 Key market trends, growth factors and opportunities

5.7.2 Market size and forecast, by region

5.7.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Chronic Obstructive Pulmonary Disease

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Asthma

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

6.4 Chronic Shortness of Breath

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market analysis by country

6.5 Restrictive Lung Disease

6.5.1 Key market trends, growth factors and opportunities

6.5.2 Market size and forecast, by region

6.5.3 Market analysis by country

6.6 Others

6.6.1 Key market trends, growth factors and opportunities

6.6.2 Market size and forecast, by region

6.6.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 Hospital

7.2.1 Key market trends, growth factors and opportunities

7.2.2 Market size and forecast, by region

7.2.3 Market analysis by country

7.3 Clinical laboratories

7.3.1 Key market trends, growth factors and opportunities

7.3.2 Market size and forecast, by region

7.3.3 Market analysis by country

7.4 Diagnostic Laboratories

7.4.1 Key market trends, growth factors and opportunities

7.4.2 Market size and forecast, by region

7.4.3 Market analysis by country

7.5 Others

7.5.1 Key market trends, growth factors and opportunities

7.5.2 Market size and forecast, by region

7.5.3 Market analysis by country

8.1 Overview

8.1.1 Market size and forecast

8.2 North America

8.2.1 Key trends and opportunities

8.2.2 North America Market size and forecast, by Product

8.2.2.1 North America Portable PFT Devices Pulmonary Function Testing Devices Market by Type

8.2.2.2 North America Complete PFT Devices Pulmonary Function Testing Devices Market by Type

8.2.3 North America Market size and forecast, by Test Type

8.2.4 North America Market size and forecast, by Application

8.2.5 North America Market size and forecast, by End user

8.2.6 North America Market size and forecast, by country

8.2.6.1 U.S.

8.2.6.1.1 Market size and forecast, by Product

8.2.6.1.2 Market size and forecast, by Test Type

8.2.6.1.3 Market size and forecast, by Application

8.2.6.1.4 Market size and forecast, by End user

8.2.6.2 Canada

8.2.6.2.1 Market size and forecast, by Product

8.2.6.2.2 Market size and forecast, by Test Type

8.2.6.2.3 Market size and forecast, by Application

8.2.6.2.4 Market size and forecast, by End user

8.2.6.3 Mexico

8.2.6.3.1 Market size and forecast, by Product

8.2.6.3.2 Market size and forecast, by Test Type

8.2.6.3.3 Market size and forecast, by Application

8.2.6.3.4 Market size and forecast, by End user

8.3 Europe

8.3.1 Key trends and opportunities

8.3.2 Europe Market size and forecast, by Product

8.3.2.1 Europe Portable PFT Devices Pulmonary Function Testing Devices Market by Type

8.3.2.2 Europe Complete PFT Devices Pulmonary Function Testing Devices Market by Type

8.3.3 Europe Market size and forecast, by Test Type

8.3.4 Europe Market size and forecast, by Application

8.3.5 Europe Market size and forecast, by End user

8.3.6 Europe Market size and forecast, by country

8.3.6.1 France

8.3.6.1.1 Market size and forecast, by Product

8.3.6.1.2 Market size and forecast, by Test Type

8.3.6.1.3 Market size and forecast, by Application

8.3.6.1.4 Market size and forecast, by End user

8.3.6.2 Germany

8.3.6.2.1 Market size and forecast, by Product

8.3.6.2.2 Market size and forecast, by Test Type

8.3.6.2.3 Market size and forecast, by Application

8.3.6.2.4 Market size and forecast, by End user

8.3.6.3 Italy

8.3.6.3.1 Market size and forecast, by Product

8.3.6.3.2 Market size and forecast, by Test Type

8.3.6.3.3 Market size and forecast, by Application

8.3.6.3.4 Market size and forecast, by End user

8.3.6.4 UK

8.3.6.4.1 Market size and forecast, by Product

8.3.6.4.2 Market size and forecast, by Test Type

8.3.6.4.3 Market size and forecast, by Application

8.3.6.4.4 Market size and forecast, by End user

8.3.6.5 Spain

8.3.6.5.1 Market size and forecast, by Product

8.3.6.5.2 Market size and forecast, by Test Type

8.3.6.5.3 Market size and forecast, by Application

8.3.6.5.4 Market size and forecast, by End user

8.3.6.6 Rest of Europe

8.3.6.6.1 Market size and forecast, by Product

8.3.6.6.2 Market size and forecast, by Test Type

8.3.6.6.3 Market size and forecast, by Application

8.3.6.6.4 Market size and forecast, by End user

8.4 Asia-Pacific

8.4.1 Key trends and opportunities

8.4.2 Asia-Pacific Market size and forecast, by Product

8.4.2.1 Asia-Pacific Portable PFT Devices Pulmonary Function Testing Devices Market by Type

8.4.2.2 Asia-Pacific Complete PFT Devices Pulmonary Function Testing Devices Market by Type

8.4.3 Asia-Pacific Market size and forecast, by Test Type

8.4.4 Asia-Pacific Market size and forecast, by Application

8.4.5 Asia-Pacific Market size and forecast, by End user

8.4.6 Asia-Pacific Market size and forecast, by country

8.4.6.1 Japan

8.4.6.1.1 Market size and forecast, by Product

8.4.6.1.2 Market size and forecast, by Test Type

8.4.6.1.3 Market size and forecast, by Application

8.4.6.1.4 Market size and forecast, by End user

8.4.6.2 China

8.4.6.2.1 Market size and forecast, by Product

8.4.6.2.2 Market size and forecast, by Test Type

8.4.6.2.3 Market size and forecast, by Application

8.4.6.2.4 Market size and forecast, by End user

8.4.6.3 India

8.4.6.3.1 Market size and forecast, by Product

8.4.6.3.2 Market size and forecast, by Test Type

8.4.6.3.3 Market size and forecast, by Application

8.4.6.3.4 Market size and forecast, by End user

8.4.6.4 Australia

8.4.6.4.1 Market size and forecast, by Product

8.4.6.4.2 Market size and forecast, by Test Type

8.4.6.4.3 Market size and forecast, by Application

8.4.6.4.4 Market size and forecast, by End user

8.4.6.5 South Korea

8.4.6.5.1 Market size and forecast, by Product

8.4.6.5.2 Market size and forecast, by Test Type

8.4.6.5.3 Market size and forecast, by Application

8.4.6.5.4 Market size and forecast, by End user

8.4.6.6 Rest of Asia-Pacific

8.4.6.6.1 Market size and forecast, by Product

8.4.6.6.2 Market size and forecast, by Test Type

8.4.6.6.3 Market size and forecast, by Application

8.4.6.6.4 Market size and forecast, by End user

8.5 LAMEA

8.5.1 Key trends and opportunities

8.5.2 LAMEA Market size and forecast, by Product

8.5.2.1 LAMEA Portable PFT Devices Pulmonary Function Testing Devices Market by Type

8.5.2.2 LAMEA Complete PFT Devices Pulmonary Function Testing Devices Market by Type

8.5.3 LAMEA Market size and forecast, by Test Type

8.5.4 LAMEA Market size and forecast, by Application

8.5.5 LAMEA Market size and forecast, by End user

8.5.6 LAMEA Market size and forecast, by country

8.5.6.1 Brazil

8.5.6.1.1 Market size and forecast, by Product

8.5.6.1.2 Market size and forecast, by Test Type

8.5.6.1.3 Market size and forecast, by Application

8.5.6.1.4 Market size and forecast, by End user

8.5.6.2 Saudi Arabia

8.5.6.2.1 Market size and forecast, by Product

8.5.6.2.2 Market size and forecast, by Test Type

8.5.6.2.3 Market size and forecast, by Application

8.5.6.2.4 Market size and forecast, by End user

8.5.6.3 South Africa

8.5.6.3.1 Market size and forecast, by Product

8.5.6.3.2 Market size and forecast, by Test Type

8.5.6.3.3 Market size and forecast, by Application

8.5.6.3.4 Market size and forecast, by End user

8.5.6.4 Rest of LAMEA

8.5.6.4.1 Market size and forecast, by Product

8.5.6.4.2 Market size and forecast, by Test Type

8.5.6.4.3 Market size and forecast, by Application

8.5.6.4.4 Market size and forecast, by End user

9.1. Introduction

9.2. Top winning strategies

9.3. Product Mapping of Top 10 Player

9.4. Competitive Dashboard

9.5. Competitive Heatmap

9.6. Key developments

10.1 SCHILLER

10.1.1 Company overview

10.1.2 Company snapshot

10.1.3 Operating business segments

10.1.4 Product portfolio

10.1.5 Business performance

10.1.6 Key strategic moves and developments

10.2 COSMED srl

10.2.1 Company overview

10.2.2 Company snapshot

10.2.3 Operating business segments

10.2.4 Product portfolio

10.2.5 Business performance

10.2.6 Key strategic moves and developments

10.3 NSPIRE HEALTH INC

10.3.1 Company overview

10.3.2 Company snapshot

10.3.3 Operating business segments

10.3.4 Product portfolio

10.3.5 Business performance

10.3.6 Key strategic moves and developments

10.4 MGC Diagnostics Corporation

10.4.1 Company overview

10.4.2 Company snapshot

10.4.3 Operating business segments

10.4.4 Product portfolio

10.4.5 Business performance

10.4.6 Key strategic moves and developments

10.5 ndd Medizintechnik AG

10.5.1 Company overview

10.5.2 Company snapshot

10.5.3 Operating business segments

10.5.4 Product portfolio

10.5.5 Business performance

10.5.6 Key strategic moves and developments

10.6 Morgan Scientific Inc.,

10.6.1 Company overview

10.6.2 Company snapshot

10.6.3 Operating business segments

10.6.4 Product portfolio

10.6.5 Business performance

10.6.6 Key strategic moves and developments

10.7 Ganshorn Medizin Electronic

10.7.1 Company overview

10.7.2 Company snapshot

10.7.3 Operating business segments

10.7.4 Product portfolio

10.7.5 Business performance

10.7.6 Key strategic moves and developments

10.8 Minato Holdings Inc

10.8.1 Company overview

10.8.2 Company snapshot

10.8.3 Operating business segments

10.8.4 Product portfolio

10.8.5 Business performance

10.8.6 Key strategic moves and developments

10.9 CHEST M.I., Inc

10.9.1 Company overview

10.9.2 Company snapshot

10.9.3 Operating business segments

10.9.4 Product portfolio

10.9.5 Business performance

10.9.6 Key strategic moves and developments

10.10 Medical Equipment Europe

10.10.1 Company overview

10.10.2 Company snapshot

10.10.3 Operating business segments

10.10.4 Product portfolio

10.10.5 Business performance

10.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 2. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR PORTABLE PFT DEVICES, BY REGION, 2021-2031 ($MILLION)

TABLE 3. PULMONARY FUNCTION TESTING DEVICES MARKET FOR PORTABLE PFT DEVICES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 4. GLOBAL PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 5. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)

TABLE 6. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)

TABLE 7. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR COMPLETE PFT DEVICES, BY REGION, 2021-2031 ($MILLION)

TABLE 8. PULMONARY FUNCTION TESTING DEVICES MARKET FOR COMPLETE PFT DEVICES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 9. GLOBAL COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 10. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)

TABLE 11. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)

TABLE 12. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 13. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SPIROMETRY, BY REGION, 2021-2031 ($MILLION)

TABLE 14. PULMONARY FUNCTION TESTING DEVICES MARKET FOR SPIROMETRY, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 15. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR PEAK FLOW METER, BY REGION, 2021-2031 ($MILLION)

TABLE 16. PULMONARY FUNCTION TESTING DEVICES MARKET FOR PEAK FLOW METER, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 17. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR LUNG VOLUME TEST, BY REGION, 2021-2031 ($MILLION)

TABLE 18. PULMONARY FUNCTION TESTING DEVICES MARKET FOR LUNG VOLUME TEST, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 19. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR GAS EXCHANGE TESTING, BY REGION, 2021-2031 ($MILLION)

TABLE 20. PULMONARY FUNCTION TESTING DEVICES MARKET FOR GAS EXCHANGE TESTING, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 21. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR MAXIMAL VOLUNTARY VENTILATION, BY REGION, 2021-2031 ($MILLION)

TABLE 22. PULMONARY FUNCTION TESTING DEVICES MARKET FOR MAXIMAL VOLUNTARY VENTILATION, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 23. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 24. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 25. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 26. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2021-2031 ($MILLION)

TABLE 27. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 28. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR ASTHMA, BY REGION, 2021-2031 ($MILLION)

TABLE 29. PULMONARY FUNCTION TESTING DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 30. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CHRONIC SHORTNESS OF BREATH, BY REGION, 2021-2031 ($MILLION)

TABLE 31. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CHRONIC SHORTNESS OF BREATH, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 32. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR RESTRICTIVE LUNG DISEASE, BY REGION, 2021-2031 ($MILLION)

TABLE 33. PULMONARY FUNCTION TESTING DEVICES MARKET FOR RESTRICTIVE LUNG DISEASE, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 34. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 35. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 36. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 37. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HOSPITAL, BY REGION, 2021-2031 ($MILLION)

TABLE 38. PULMONARY FUNCTION TESTING DEVICES MARKET FOR HOSPITAL, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 39. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CLINICAL LABORATORIES, BY REGION, 2021-2031 ($MILLION)

TABLE 40. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 41. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)

TABLE 42. PULMONARY FUNCTION TESTING DEVICES MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 43. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 44. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 45. PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 46. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 47. NORTH AMERICA PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 48. NORTH AMERICA COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 49. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 50. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 51. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 52. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 53. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 54. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 55. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 56. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 57. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 58. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 59. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 60. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 61. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 62. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 63. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 64. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 65. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 66. EUROPE PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 67. EUROPE COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 68. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 69. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 70. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 71. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 72. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 73. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 74. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 75. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 76. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 77. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 78. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 79. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 80. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 81. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 82. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 83. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 84. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 85. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 86. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 87. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 88. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 89. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 90. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 91. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 92. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 93. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 94. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 95. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 96. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 97. ASIA-PACIFIC PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 98. ASIA-PACIFIC COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 99. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 100. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 101. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 102. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 103. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 104. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 105. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 106. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 107. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 108. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 109. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 110. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 111. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 112. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 113. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 114. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 115. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 116. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 117. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 118. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 119. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 120. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 121. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 122. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 123. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 124. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 125. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 126. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 127. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 128. LAMEA PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 129. LAMEA COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)

TABLE 130. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 131. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 132. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 133. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 134. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 135. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 136. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 137. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 138. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 139. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 140. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 141. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 142. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 143. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 144. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 145. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 146. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 147. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)

TABLE 148. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 149. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 150.SCHILLER: COMPANY SNAPSHOT

TABLE 151.SCHILLER: OPERATING SEGMENTS

TABLE 152.SCHILLER: PRODUCT PORTFOLIO

TABLE 153.SCHILLER: NET SALES,

TABLE 154.SCHILLER: KEY STRATERGIES

TABLE 155.COSMED SRL: COMPANY SNAPSHOT

TABLE 156.COSMED SRL: OPERATING SEGMENTS

TABLE 157.COSMED SRL: PRODUCT PORTFOLIO

TABLE 158.COSMED SRL: NET SALES,

TABLE 159.COSMED SRL: KEY STRATERGIES

TABLE 160.NSPIRE HEALTH INC: COMPANY SNAPSHOT

TABLE 161.NSPIRE HEALTH INC: OPERATING SEGMENTS

TABLE 162.NSPIRE HEALTH INC: PRODUCT PORTFOLIO

TABLE 163.NSPIRE HEALTH INC: NET SALES,

TABLE 164.NSPIRE HEALTH INC: KEY STRATERGIES

TABLE 165.MGC DIAGNOSTICS CORPORATION: COMPANY SNAPSHOT

TABLE 166.MGC DIAGNOSTICS CORPORATION: OPERATING SEGMENTS

TABLE 167.MGC DIAGNOSTICS CORPORATION: PRODUCT PORTFOLIO

TABLE 168.MGC DIAGNOSTICS CORPORATION: NET SALES,

TABLE 169.MGC DIAGNOSTICS CORPORATION: KEY STRATERGIES

TABLE 170.NDD MEDIZINTECHNIK AG: COMPANY SNAPSHOT

TABLE 171.NDD MEDIZINTECHNIK AG: OPERATING SEGMENTS

TABLE 172.NDD MEDIZINTECHNIK AG: PRODUCT PORTFOLIO

TABLE 173.NDD MEDIZINTECHNIK AG: NET SALES,

TABLE 174.NDD MEDIZINTECHNIK AG: KEY STRATERGIES

TABLE 175.MORGAN SCIENTIFIC INC.,: COMPANY SNAPSHOT

TABLE 176.MORGAN SCIENTIFIC INC.,: OPERATING SEGMENTS

TABLE 177.MORGAN SCIENTIFIC INC.,: PRODUCT PORTFOLIO

TABLE 178.MORGAN SCIENTIFIC INC.,: NET SALES,

TABLE 179.MORGAN SCIENTIFIC INC.,: KEY STRATERGIES

TABLE 180.GANSHORN MEDIZIN ELECTRONIC: COMPANY SNAPSHOT

TABLE 181.GANSHORN MEDIZIN ELECTRONIC: OPERATING SEGMENTS

TABLE 182.GANSHORN MEDIZIN ELECTRONIC: PRODUCT PORTFOLIO

TABLE 183.GANSHORN MEDIZIN ELECTRONIC: NET SALES,

TABLE 184.GANSHORN MEDIZIN ELECTRONIC: KEY STRATERGIES

TABLE 185.MINATO HOLDINGS INC: COMPANY SNAPSHOT

TABLE 186.MINATO HOLDINGS INC: OPERATING SEGMENTS

TABLE 187.MINATO HOLDINGS INC: PRODUCT PORTFOLIO

TABLE 188.MINATO HOLDINGS INC: NET SALES,

TABLE 189.MINATO HOLDINGS INC: KEY STRATERGIES

TABLE 190.CHEST M.I., INC: COMPANY SNAPSHOT

TABLE 191.CHEST M.I., INC: OPERATING SEGMENTS

TABLE 192.CHEST M.I., INC: PRODUCT PORTFOLIO

TABLE 193.CHEST M.I., INC: NET SALES,

TABLE 194.CHEST M.I., INC: KEY STRATERGIES

TABLE 195.MEDICAL EQUIPMENT EUROPE: COMPANY SNAPSHOT

TABLE 196.MEDICAL EQUIPMENT EUROPE: OPERATING SEGMENTS

TABLE 197.MEDICAL EQUIPMENT EUROPE: PRODUCT PORTFOLIO

TABLE 198.MEDICAL EQUIPMENT EUROPE: NET SALES,

TABLE 199.MEDICAL EQUIPMENT EUROPE: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.PULMONARY FUNCTION TESTING DEVICES MARKET SEGMENTATION

FIGURE 2.PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031

FIGURE 3.PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.PULMONARY FUNCTION TESTING DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.PULMONARY FUNCTION TESTING DEVICES MARKET,BY PRODUCT,2021(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 15.PULMONARY FUNCTION TESTING DEVICES MARKET,BY TEST TYPE,2021(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SPIROMETRY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PEAK FLOW METER PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF LUNG VOLUME TEST PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF GAS EXCHANGE TESTING PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MAXIMAL VOLUNTARY VENTILATION PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 22.PULMONARY FUNCTION TESTING DEVICES MARKET,BY APPLICATION,2021(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ASTHMA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 25.COMPARATIVE SHARE ANALYSIS OF CHRONIC SHORTNESS OF BREATH PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 26.COMPARATIVE SHARE ANALYSIS OF RESTRICTIVE LUNG DISEASE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 28.PULMONARY FUNCTION TESTING DEVICES MARKET,BY END USER,2021(%)

FIGURE 29.COMPARATIVE SHARE ANALYSIS OF HOSPITAL PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 30.COMPARATIVE SHARE ANALYSIS OF CLINICAL LABORATORIES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 31.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABORATORIES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 32.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)

FIGURE 33.PULMONARY FUNCTION TESTING DEVICES MARKET BY REGION,2021

FIGURE 34.U.S. PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 35.CANADA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 36.MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 37.FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 38.GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 39.ITALY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 40.UK PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 41.SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 42.REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 43.JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 44.CHINA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 45.INDIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 46.AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 47.SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 48.REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 49.BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 50.SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 51.SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 52.REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)

FIGURE 53. TOP WINNING STRATEGIES, BY YEAR

FIGURE 54. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 55. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 56.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 57.COMPETITIVE DASHBOARD

FIGURE 58.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 59.SCHILLER.: NET SALES ,($MILLION)

FIGURE 60.COSMED SRL.: NET SALES ,($MILLION)

FIGURE 61.NSPIRE HEALTH INC.: NET SALES ,($MILLION)

FIGURE 62.MGC DIAGNOSTICS CORPORATION.: NET SALES ,($MILLION)

FIGURE 63.NDD MEDIZINTECHNIK AG.: NET SALES ,($MILLION)

FIGURE 64.MORGAN SCIENTIFIC INC.,.: NET SALES ,($MILLION)

FIGURE 65.GANSHORN MEDIZIN ELECTRONIC.: NET SALES ,($MILLION)

FIGURE 66.MINATO HOLDINGS INC.: NET SALES ,($MILLION)

FIGURE 67.CHEST M.I., INC.: NET SALES ,($MILLION)

FIGURE 68.MEDICAL EQUIPMENT EUROPE.: NET SALES ,($MILLION